secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (—)
CIK:        0001419051
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0001493152-23-037153
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Therapeutic Solutions increases authorized common shares from 4.5B to 5.5B
--------------------------------------------------------------------------

- Authorized common shares increased from 4.5B to 5.5B; total authorized shares now 5.505B including preferred.
- Approved via nonunanimous majority written consent on Oct 11, 2023; amendment filed Oct 12, 2023.
- Series A Preferred Stock holder (Timothy Dixon and Thomas Ichim) retains effective voting control.
- Each common share has one vote; failure to vote or abstention counted as vote against the amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419051/000149315223037153/0001493152-23-037153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419051/000149315223037153/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-037153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer